Insider Trading & Ownership - WEITZMAN DEBORAH

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for WEITZMAN DEBORAH
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-27
Sale
2023-11-29
09:14 am
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
36,642 $106.31 $3,895,411 35,202
(Direct)
View
2023-08-28
Sale
2023-08-29
4:21 pm
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
6,712 $89.81 $602,805 44,202
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-12-02
Tax Withholding
2024-12-03
4:18 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, PSS Segment
632 $122.24 49,129
(Direct)
View
2024-08-15
Option Award
2024-08-19
8:15 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, PSS Segment
13,530 $0 49,761
(Direct)
View
2024-08-15
Tax Withholding
2024-08-19
8:15 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, PSS Segment
9,918 $106.36 49,761
(Direct)
View
2024-08-16
Tax Withholding
2024-08-19
8:15 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, PSS Segment
2,341 $107.91 49,761
(Direct)
View
2024-08-13
Option Award
2024-08-14
4:29 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, PSS Segment
13,926 $0 48,490
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
4:42 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
638 $107.08 34,564
(Direct)
View
2023-11-27
Exercise
2023-11-29
09:14 am
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
6,279 $83.19 35,202
(Direct)
View
2023-11-27
Exercise
2023-11-29
09:14 am
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
15,373 $66.43 35,202
(Direct)
View
2023-11-27
Exercise
2023-11-29
09:14 am
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
5,990 $84.27 35,202
(Direct)
View
2023-11-27
Exercise
2023-11-29
09:14 am
N/A
2025-08-15
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
27,642 $0 35,202
(Direct)
View
2023-08-28
Exercise
2023-08-29
4:21 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
6,712 $71.43 44,202
(Direct)
View
2023-08-28
Exercise
2023-08-29
4:21 pm
N/A
2024-08-15
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
6,712 $0 44,202
(Direct)
View
2023-08-16
Option Award
2023-08-17
7:51 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
15,487 $0 44,202
(Direct)
View
2023-08-15
Tax Withholding
2023-08-17
7:51 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
10,966 $92.99 44,202
(Direct)
View
2023-08-07
Option Award
2023-08-08
7:42 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
12,760 $0 39,681
(Direct)
View
2022-12-01
Tax Withholding
2022-12-05
4:29 pm
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
380 $80.17 26,921
(Direct)
View

Ownership
2022-09-29
08:31 am
N/A
N/A
CARDINAL HEALTH INC CAH WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
0 $0 61,655
(Direct)
View